139 related articles for article (PubMed ID: 3444378)
1. Metabolism of ether phospholipids and analogs in neoplastic cells.
Fleer EA; Unger C; Kim DJ; Eibl H
Lipids; 1987 Nov; 22(11):856-61. PubMed ID: 3444378
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
3. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.
Trulla LL; Magistrelli A; Salmona M; Tacconi MT
Lipids; 1993 May; 28(5):403-6. PubMed ID: 8316047
[TBL] [Abstract][Full Text] [Related]
5. Subcellular fractions of bovine brain degrade phosphatidylcholine by sequential deacylation of the sn-1 and sn-2 positions.
Pete MJ; Wu DW; Exton JH
Biochim Biophys Acta; 1996 Feb; 1299(3):325-32. PubMed ID: 8597587
[TBL] [Abstract][Full Text] [Related]
6. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
7. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
Petersen ES; Kelley EE; Modest EJ; Burns CP
Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
[TBL] [Abstract][Full Text] [Related]
8. Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
Magistrelli A; Villa P; Benfenati E; Modest EJ; Salmona M; Tacconi MT
Drug Metab Dispos; 1995 Jan; 23(1):113-8. PubMed ID: 7720513
[TBL] [Abstract][Full Text] [Related]
9. Sequential degradation of choline phosphoglycerides by phospholipase D and phosphatidate phosphohydrolase in dibutyryl cAMP-differentiated U937 cells.
Anthes JC; Krasovsky J; Egan RW; Siegel MI; Billah MM
Arch Biochem Biophys; 1991 May; 287(1):53-9. PubMed ID: 1654804
[TBL] [Abstract][Full Text] [Related]
10. HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form.
Vallari DS; Smith ZL; Snyder F
Biochem Biophys Res Commun; 1988 Oct; 156(1):1-8. PubMed ID: 3178823
[TBL] [Abstract][Full Text] [Related]
11. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
12. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
Vogler WR; Whigham E; Bennett WD; Olson AC
Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326
[TBL] [Abstract][Full Text] [Related]
13. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
Principe P; Sidoti C; Braquet P
Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
[TBL] [Abstract][Full Text] [Related]
15. The effect of two synthetic phospholipids on cell proliferation and phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells.
Wieder T; Haase A; Geilen CC; Orfanos CE
Lipids; 1995 May; 30(5):389-93. PubMed ID: 7637558
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
Hoffman DR; Hoffman LH; Snyder F
Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of liposomes prepared from a labelled ether analog of 1,2-dioleoyl-sn-glycero-3-phosphocholine in the rat.
Stein Y; Halperin G; Leitersdorf E; Dabach Y; Hollander G; Stein O
Biochim Biophys Acta; 1984 May; 793(3):354-64. PubMed ID: 6712973
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Small GW; Strum JC; Daniel LW
Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
